pqq cofactor has been researched along with Alloxan Diabetes in 6 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND Diabetic nephropathy (DN) is one of the chronic microvascular complications of diabetes." | 1.56 | Pyrroloquinoline Quinone Inhibits Oxidative Stress in Rats with Diabetic Nephropathy. ( Peng, J; Wu, X; Xiong, Y; Zhang, J; Zhang, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, XF | 1 |
| Zhai, BZ | 1 |
| Hu, WL | 1 |
| Lou, MH | 1 |
| Chen, YH | 1 |
| Liu, YF | 1 |
| Chen, JG | 1 |
| Mei, S | 2 |
| You, ZQ | 1 |
| Liu, Z | 2 |
| Zhang, LJ | 1 |
| Zhang, YH | 1 |
| Wang, Y | 2 |
| Qu, X | 1 |
| Zhai, B | 1 |
| Liu, Y | 1 |
| Chen, Y | 1 |
| Xie, Z | 1 |
| Wang, Q | 1 |
| Wu, Y | 1 |
| Chen, J | 1 |
| Wu, J | 1 |
| You, Z | 1 |
| Yu, Y | 1 |
| Zhang, M | 1 |
| Zhang, J | 1 |
| Xiong, Y | 1 |
| Peng, J | 1 |
| Wu, X | 1 |
| Kumar, N | 2 |
| Kar, A | 2 |
| Takada, M | 1 |
| Sumi, M | 1 |
| Maeda, A | 1 |
| Watanabe, F | 1 |
| Kamiya, T | 1 |
| Ishii, T | 1 |
| Nakano, M | 1 |
| Akagawa, M | 1 |
6 other studies available for pqq cofactor and Alloxan Diabetes
| Article | Year |
|---|---|
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Glucose | 2022 |
Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
Topics: Animals; Caspase 1; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glucose; Huma | 2022 |
Pyrroloquinoline Quinone Inhibits Oxidative Stress in Rats with Diabetic Nephropathy.
Topics: Adenylate Kinase; Animals; Blood Glucose; Blood Urea Nitrogen; Cell Line; Creatinine; Diabetes Melli | 2020 |
Pyrroloquinoline quinone ameliorates oxidative stress and lipid peroxidation in the brain of streptozotocin-induced diabetic mice.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Lipid Peroxidation; Male; Mice; Oxidative Stress; P | 2015 |
Pyrroloquinoline quinone (PQQ) has potential to ameliorate streptozotocin-induced diabetes mellitus and oxidative stress in mice: A histopathological and biochemical study.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Insulin; Lipids; Liver; Male; | 2015 |
Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose Into | 2012 |